Overview
Almerindo Portfolio is an Ophthalmologist practicing medicine in New York, New York.
His clinical expertise encompasses Cataract, Dry Eye Syndrome, Glaucoma, and Neuroretinitis.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- PPO
- EPO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
310 E 14th St, New York, NY 10003
David S Chu MD
Mark Kupersmith is an Ophthalmologist practicing medicine in New York, New York. Dr. Kupersmith is highly rated in 52 conditions, according to our data. His clinical expertise encompasses Papilledema, Increased Intracranial Pressure, Pseudotumor Cerebri Syndrome, Optic Neuritis, and Thymectomy.
New York Eye Surgery Associates PLLC
Nathan Radcliffe is an Ophthalmologist practicing medicine in Bronx, New York. Dr. Radcliffe is highly rated in 36 conditions, according to our data. His clinical expertise encompasses Glaucoma, Ocular Hypertension (OHT), Cataract, Trabeculectomy, and Cataract Removal.
Vitreous Retina Macula Consultants Of New York
Richard Spaide is an Ophthalmologist practicing medicine in New York, New York. Dr. Spaide is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Central Serous Chorioretinopathy, Geographic Atrophy, and Vitrectomy.
Frequently Asked Questions about Dr. Almerindo Portfolio
How do I make an appointment with Dr. Almerindo Portfolio?
You can book an appointment with Dr. Almerindo Portfolio by calling their office at 201-445-5161. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Almerindo Portfolio a top-rated expert for Cataract?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Almerindo Portfolio is classified as an Experienced expert for Cataract, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Almerindo Portfolio specialize in?
While Dr. Almerindo Portfolio is a Ophthalmology, they have specific expertise in Cataract, Dry Eye Syndrome, and Glaucoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Ophthalmology.
Does Dr. Almerindo Portfolio accept my insurance?
Dr. Almerindo Portfolio accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 201-445-5161 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- CataractDr. Portfolio isExperienced. Learn about Cataract.
- Dry Eye SyndromeDr. Portfolio isExperienced. Learn about Dry Eye Syndrome.
- GlaucomaDr. Portfolio isExperienced. Learn about Glaucoma.
- Late-Onset Retinal DegenerationDr. Portfolio isExperienced. Learn about Late-Onset Retinal Degeneration.
- NeuroretinitisDr. Portfolio isExperienced. Learn about Neuroretinitis.
- Ocular Hypertension (OHT)Dr. Portfolio isExperienced. Learn about Ocular Hypertension (OHT).